Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965265928> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2965265928 endingPage "2569" @default.
- W2965265928 startingPage "2569" @default.
- W2965265928 abstract "2569 Background: Identification of tumor-associated antigens (TAA) have resulted in the development of therapeutic vaccines for the treatment of cancer. We applied an integrated functional genomics approach to identify TAA in malignant tissues of patients with renal cell carcinoma (RCC). Methods: A comparative DNA chip analysis of tumor and the corresponding non-malignant tissue from patients with RCC followed by sequencing of peptides bound to the HLA-class I molecules by mass spectrometry was applied to identify novel TAA in RCC. To confirm the immunogenicity of identified epitopes cytotoxic T lymphocytes (CTL) were generated using dendritic cells (DC). Results: RGS5 was found to be overexpressed in 16 of 29 analyzed RCC (5.7–29.9 fold) as compared to non-malignant renal tissue. Two peptides derived from RGS5 binding to either HLA-A*02 or 03 were identified. RGS5 was previously shown to be expressed in pericytes and promote tumor angiogenesis. Using RT-PCR analysis we found that RGS5 is expressed on a broad variety of tumor cells including RCC, colorectal, breast and ovarian cancer, malignant melanoma and multiple myeloma as well as in acute and chronic leukemias making this protein an interesting candidate for the development of vaccination strategies to target the tumor cells and the tumor vessels. CTL that were induced using the RGS5 peptides lysed autologous DC pulsed with the cognate peptide or transfected with in vitro transcribed RGS5 RNA as well as HLA-matched tumor cell lines. The specificity and HLA restriction was confirmed using blocking monoclonal antibodies and in cold-target inhibition assays. We next utilized DC transfected with RGS5 RNA to generate specific CTL. Using this approach we confirmed the processing and presentation of the identified peptides by malignant cells. These CTL lysed tumor cells in antigen specific manner while sparing non-malignant cells. In an ongoing vaccine trial RGS5 peptides could safely be given to RCC patients resulting in the induction of peptide specific CTL responses. Conclusions: Our results demonstrate that RGS5 is a novel tumor rejection antigen expressed in a wide range of malignancies that can be applied to target malignant cells and tumor angiogenesis. [Table: see text]" @default.
- W2965265928 created "2019-08-13" @default.
- W2965265928 creator A5012626247 @default.
- W2965265928 creator A5014277422 @default.
- W2965265928 creator A5015612107 @default.
- W2965265928 creator A5042884841 @default.
- W2965265928 creator A5066624700 @default.
- W2965265928 creator A5085265624 @default.
- W2965265928 creator A5085504780 @default.
- W2965265928 creator A5091245862 @default.
- W2965265928 date "2006-06-20" @default.
- W2965265928 modified "2023-10-16" @default.
- W2965265928 title "Identification of RGS5 as a tumor-associated antigen expressed in a broad range of human malignancies and recognized by antigen specific cytotoxic T cells" @default.
- W2965265928 doi "https://doi.org/10.1200/jco.2006.24.18_suppl.2569" @default.
- W2965265928 hasPublicationYear "2006" @default.
- W2965265928 type Work @default.
- W2965265928 sameAs 2965265928 @default.
- W2965265928 citedByCount "0" @default.
- W2965265928 crossrefType "journal-article" @default.
- W2965265928 hasAuthorship W2965265928A5012626247 @default.
- W2965265928 hasAuthorship W2965265928A5014277422 @default.
- W2965265928 hasAuthorship W2965265928A5015612107 @default.
- W2965265928 hasAuthorship W2965265928A5042884841 @default.
- W2965265928 hasAuthorship W2965265928A5066624700 @default.
- W2965265928 hasAuthorship W2965265928A5085265624 @default.
- W2965265928 hasAuthorship W2965265928A5085504780 @default.
- W2965265928 hasAuthorship W2965265928A5091245862 @default.
- W2965265928 hasConcept C147483822 @default.
- W2965265928 hasConcept C147969180 @default.
- W2965265928 hasConcept C154317977 @default.
- W2965265928 hasConcept C159654299 @default.
- W2965265928 hasConcept C167672396 @default.
- W2965265928 hasConcept C188280979 @default.
- W2965265928 hasConcept C195616568 @default.
- W2965265928 hasConcept C202751555 @default.
- W2965265928 hasConcept C203014093 @default.
- W2965265928 hasConcept C2776662205 @default.
- W2965265928 hasConcept C2777701055 @default.
- W2965265928 hasConcept C2780674031 @default.
- W2965265928 hasConcept C2780868878 @default.
- W2965265928 hasConcept C502942594 @default.
- W2965265928 hasConcept C542903549 @default.
- W2965265928 hasConcept C55493867 @default.
- W2965265928 hasConcept C71924100 @default.
- W2965265928 hasConcept C86803240 @default.
- W2965265928 hasConcept C8891405 @default.
- W2965265928 hasConceptScore W2965265928C147483822 @default.
- W2965265928 hasConceptScore W2965265928C147969180 @default.
- W2965265928 hasConceptScore W2965265928C154317977 @default.
- W2965265928 hasConceptScore W2965265928C159654299 @default.
- W2965265928 hasConceptScore W2965265928C167672396 @default.
- W2965265928 hasConceptScore W2965265928C188280979 @default.
- W2965265928 hasConceptScore W2965265928C195616568 @default.
- W2965265928 hasConceptScore W2965265928C202751555 @default.
- W2965265928 hasConceptScore W2965265928C203014093 @default.
- W2965265928 hasConceptScore W2965265928C2776662205 @default.
- W2965265928 hasConceptScore W2965265928C2777701055 @default.
- W2965265928 hasConceptScore W2965265928C2780674031 @default.
- W2965265928 hasConceptScore W2965265928C2780868878 @default.
- W2965265928 hasConceptScore W2965265928C502942594 @default.
- W2965265928 hasConceptScore W2965265928C542903549 @default.
- W2965265928 hasConceptScore W2965265928C55493867 @default.
- W2965265928 hasConceptScore W2965265928C71924100 @default.
- W2965265928 hasConceptScore W2965265928C86803240 @default.
- W2965265928 hasConceptScore W2965265928C8891405 @default.
- W2965265928 hasIssue "18_suppl" @default.
- W2965265928 hasLocation W29652659281 @default.
- W2965265928 hasOpenAccess W2965265928 @default.
- W2965265928 hasPrimaryLocation W29652659281 @default.
- W2965265928 hasRelatedWork W1604248381 @default.
- W2965265928 hasRelatedWork W195682249 @default.
- W2965265928 hasRelatedWork W2001280522 @default.
- W2965265928 hasRelatedWork W2003120136 @default.
- W2965265928 hasRelatedWork W2052457630 @default.
- W2965265928 hasRelatedWork W2069639706 @default.
- W2965265928 hasRelatedWork W2104030698 @default.
- W2965265928 hasRelatedWork W2380647059 @default.
- W2965265928 hasRelatedWork W3030900991 @default.
- W2965265928 hasRelatedWork W4304687774 @default.
- W2965265928 hasVolume "24" @default.
- W2965265928 isParatext "false" @default.
- W2965265928 isRetracted "false" @default.
- W2965265928 magId "2965265928" @default.
- W2965265928 workType "article" @default.